Pentwater Capital Management LP Lyra Therapeutics, Inc. Transaction History

Pentwater Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.12 - $7.51 $247,200 - $450,600	-60,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $5.36 $39,595 - $60,637	-11,313 Reduced 15.86%	60,000 $241,000
Q4 2021 Feb 11, 2022	BUY	$4.22 - $9.41 $165,841 - $369,803	39,299 Added 122.76%	71,313 $311,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $49,776 - $77,458	8,214 Added 34.51%	32,014 $292,000
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $259,658 - $441,727	23,800 New	23,800 $270,000

32M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.05M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.